Immune checkpoint inhibitor-related alopecia: Insight into the pathophysiology utilizing non-invasive diagnostic techniques

J Dermatol. 2019 May;46(5):e152-e153. doi: 10.1111/1346-8138.14736. Epub 2019 Jan 4.

Authors

Misaki Kinoshita-Ise^{1

2}, F Stuart Foster^{3

4}, Neil H Shear¹

Affiliations

¹ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
² Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
³ Sunnybrook Research Institute, Toronto, Canada.
⁴ Department of Medical Biophysics, University of Toronto, Toronto, Canada.

PMID: 30614046
DOI: 10.1111/1346-8138.14736

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Topical
Aged
Alopecia / diagnostic imaging
Alopecia / drug therapy
Alopecia / immunology*
Alopecia / pathology
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological / administration & dosage
Antineoplastic Agents, Immunological / adverse effects*
B7-H1 Antigen / antagonists & inhibitors
B7-H1 Antigen / immunology
Clobetasol / administration & dosage
Female
Glucocorticoids / administration & dosage
Hair / diagnostic imaging
Hair / drug effects
Hair / pathology*
Humans
Minoxidil / administration & dosage
Treatment Outcome
Ultrasonography
Ureteral Neoplasms / drug therapy
Ureteral Neoplasms / immunology

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
B7-H1 Antigen
CD274 protein, human
Glucocorticoids
atezolizumab
Minoxidil
Clobetasol